Coursey K, Muralidhar K, Srinivas V, Jaykrishna P, Begum F, Ningaiah N
BMC Public Health. 2024; 24(1):2139.
PMID: 39112938
PMC: 11304586.
DOI: 10.1186/s12889-024-19485-8.
Shrestha R, Alias H, Wong L, Altice F, Lim S
BMC Public Health. 2020; 20(1):1777.
PMID: 33238941
PMC: 7687720.
DOI: 10.1186/s12889-020-09832-w.
Gautam B, Sapkota V, Wagle R
Hum Resour Health. 2019; 17(1):96.
PMID: 31815631
PMC: 6902550.
DOI: 10.1186/s12960-019-0427-8.
Fiorentino M, Protiere C, Sagaon-Teyssier L, Mimi M, Fressard L, Arnold M
J Virus Erad. 2019; 5(3):152-162.
PMID: 31700661
PMC: 6816119.
Shrestha R, Karki P, Altice F, Dubov O, Fraenkel L, Huedo-Medina T
AIDS Behav. 2017; 22(4):1228-1238.
PMID: 28695388
PMC: 5762432.
DOI: 10.1007/s10461-017-1851-1.
Understanding Preferences for Treatment After Hypothetical First-Time Anterior Shoulder Dislocation: Surveying an Online Panel Utilizing a Novel Shared Decision-Making Tool.
Streufert B, Reed S, Orlando L, Taylor D, Huber J, Mather 3rd R
Orthop J Sports Med. 2017; 5(3):2325967117695788.
PMID: 28377932
PMC: 5363455.
DOI: 10.1177/2325967117695788.
The development of ORACLe: a measure of an organisation's capacity to engage in evidence-informed health policy.
Makkar S, Turner T, Williamson A, Louviere J, Redman S, Haynes A
Health Res Policy Syst. 2016; 14:4.
PMID: 26769570
PMC: 4712550.
DOI: 10.1186/s12961-015-0069-9.
Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.
Poulos C, Kinter E, Yang J, Bridges J, Posner J, Reder A
Patient. 2015; 9(2):171-80.
PMID: 26259849
PMC: 4796329.
DOI: 10.1007/s40271-015-0136-x.
Using conjoint analysis to develop a system of scoring policymakers' use of research in policy and program development.
Makkar S, Williamson A, Turner T, Redman S, Louviere J
Health Res Policy Syst. 2015; 13:35.
PMID: 26238566
PMC: 4523001.
DOI: 10.1186/s12961-015-0022-y.
Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis.
Utz K, Hoog J, Wentrup A, Berg S, Lammer A, Jainsch B
Ther Adv Neurol Disord. 2014; 7(6):263-75.
PMID: 25371708
PMC: 4218877.
DOI: 10.1177/1756285614555335.
Assessment of patients' preferences regarding the characteristics associated with the treatment of chronic obstructive pulmonary disease.
Bulcun E, Ekici M, Ekici A
Int J Chron Obstruct Pulmon Dis. 2014; 9:363-8.
PMID: 24790426
PMC: 3998864.
DOI: 10.2147/COPD.S56229.
Why should regulators consider using patient preferences in benefit-risk assessment?.
van Til J, IJzerman M
Pharmacoeconomics. 2013; 32(1):1-4.
PMID: 24288209
DOI: 10.1007/s40273-013-0118-6.
A framework for organizing and selecting quantitative approaches for benefit-harm assessment.
Puhan M, Singh S, Weiss C, Varadhan R, Boyd C
BMC Med Res Methodol. 2012; 12:173.
PMID: 23163976
PMC: 3572426.
DOI: 10.1186/1471-2288-12-173.
Use of conjoint analysis to assess HIV vaccine acceptability: feasibility of an innovation in the assessment of consumer health-care preferences.
Lee S, Newman P, Comulada W, Cunningham W, Duan N
Int J STD AIDS. 2012; 23(4):235-41.
PMID: 22581945
PMC: 3372064.
DOI: 10.1258/ijsa.2011.011189.
Patient preferences and linear scoring rules for patient-reported outcomes.
Mohamed A, Hauber A, Reed Johnson F, Coon C
Patient. 2012; 3(4):217-27.
PMID: 22273431
DOI: 10.2165/11537880-000000000-00000.
Validity and Reliability of Willingness-to-Pay Estimates: Evidence from Two Overlapping Discrete-Choice Experiments.
Telser H, Becker K, Zweifel P
Patient. 2012; 1(4):283-98.
PMID: 22272996
DOI: 10.2165/1312067-200801040-00010.
Is the Nintendo Wii Fit really acceptable to older people? A discrete choice experiment.
Laver K, Ratcliffe J, George S, Burgess L, Crotty M
BMC Geriatr. 2011; 11:64.
PMID: 22011360
PMC: 3206825.
DOI: 10.1186/1471-2318-11-64.
Patient preferences for reducing toxicities of treatments for gastrointestinal stromal tumor (GIST).
Hauber A, Gonzalez J, Coombs J, Sirulnik A, Palacios D, Scherzer N
Patient Prefer Adherence. 2011; 5:307-14.
PMID: 21792302
PMC: 3140312.
DOI: 10.2147/PPA.S20445.
Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations.
Galea J, Kinsler J, Salazar X, Lee S, Giron M, Sayles J
Int J STD AIDS. 2011; 22(5):256-62.
PMID: 21571973
PMC: 3096991.
DOI: 10.1258/ijsa.2009.009255.
On the meaningfulness of testing preference axioms in stated preference discrete choice experiments.
Hougaard J, Tjur T, Osterdal L
Eur J Health Econ. 2011; 13(4):409-17.
PMID: 21544605
DOI: 10.1007/s10198-011-0312-4.